236 related articles for article (PubMed ID: 30739187)
1. Clinical and endoscopic complications of Epstein-Barr virus in inflammatory bowel disease: an illustrative case series.
Goetgebuer RL; van der Woude CJ; de Ridder L; Doukas M; de Vries AC
Int J Colorectal Dis; 2019 May; 34(5):923-926. PubMed ID: 30739187
[TBL] [Abstract][Full Text] [Related]
2. The Status of Epstein-Barr Virus Infection in Intestinal Mucosa of Chinese Patients with Inflammatory Bowel Disease.
Li X; Chen N; You P; Peng T; Chen G; Wang J; Li J; Liu Y
Digestion; 2019; 99(2):126-132. PubMed ID: 30235444
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.
Magro F; Santos-Antunes J; Albuquerque A; Vilas-Boas F; Macedo GN; Nazareth N; Lopes S; Sobrinho-Simões J; Teixeira S; Dias CC; Cabral J; Sarmento A; Macedo G
Inflamm Bowel Dis; 2013 Jul; 19(8):1710-6. PubMed ID: 23574759
[TBL] [Abstract][Full Text] [Related]
4. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.
Ciccocioppo R; Racca F; Paolucci S; Campanini G; Pozzi L; Betti E; Riboni R; Vanoli A; Baldanti F; Corazza GR
World J Gastroenterol; 2015 Feb; 21(6):1915-26. PubMed ID: 25684960
[TBL] [Abstract][Full Text] [Related]
5. A review on co-existent Epstein-Barr virus-induced complications in inflammatory bowel disease.
Wu S; He C; Tang TY; Li YQ
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1085-1091. PubMed ID: 31205127
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus associated colitis in kidney transplant patients: a case series.
Brás AC; Querido S; Mascarenhas A; Mendes R; Verissimo R; Chagas C; Weigert A
Infect Dis (Lond); 2024 May; 56(5):410-415. PubMed ID: 38459811
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.
Nissen LH; Nagtegaal ID; de Jong DJ; Kievit W; Derikx LA; Groenen PJ; van Krieken JH; Hoentjen F
J Crohns Colitis; 2015 May; 9(5):398-403. PubMed ID: 25740811
[TBL] [Abstract][Full Text] [Related]
9. A nearly fatal primary Epstein-Barr virus infection associated with low NK-cell counts in a patient receiving azathioprine: a case report and review of literature.
Honkila M; Niinimäki R; Taskinen M; Kuismin O; Kettunen K; Saarela J; Turunen S; Renko M; Tapiainen T
BMC Infect Dis; 2019 May; 19(1):404. PubMed ID: 31077135
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease.
Sankaran-Walters S; Ransibrahmanakul K; Grishina I; Hung J; Martinez E; Prindiville T; Dandekar S
J Clin Virol; 2011 Jan; 50(1):31-6. PubMed ID: 21035384
[TBL] [Abstract][Full Text] [Related]
11. Looking into Enteric Virome in Patients with IBD: Defining Guilty or Innocence?
Lopes S; Andrade P; Conde S; Liberal R; Dias CC; Fernandes S; Pinheiro J; Simões JS; Carneiro F; Magro F; Macedo G
Inflamm Bowel Dis; 2017 Aug; 23(8):1278-1284. PubMed ID: 28617757
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease exacerbation associated with Epstein-Barr virus infection.
Dimitroulia E; Pitiriga VC; Piperaki ET; Spanakis NE; Tsakris A
Dis Colon Rectum; 2013 Mar; 56(3):322-7. PubMed ID: 23392146
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression for inflammatory bowel disease does not influence Epstein-Barr viral load in the short-term.
Rodríguez-Lago I; Merino O; López de Goicoechea MJ; Aranzamendi M; Zubiaurre L; Muro N; Ortiz de Zárate J; Cilla G; Cabriada JL
Gastroenterol Hepatol; 2019 Nov; 42(9):542-547. PubMed ID: 31402179
[TBL] [Abstract][Full Text] [Related]
14. Differential cellular localization of Epstein-Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease.
Ciccocioppo R; Racca F; Scudeller L; Piralla A; Formagnana P; Pozzi L; Betti E; Vanoli A; Riboni R; Kruzliak P; Baldanti F; Corazza GR
Immunol Res; 2016 Feb; 64(1):191-203. PubMed ID: 26659090
[TBL] [Abstract][Full Text] [Related]
15. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
[TBL] [Abstract][Full Text] [Related]
16. Impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease.
de Francisco R; Castaño-García A; Martínez-González S; Pérez-Martínez I; González-Huerta AJ; Morais LR; Fernández-García MS; Jiménez S; Díaz-Coto S; Flórez-Díez P; Suárez A; Riestra S
Aliment Pharmacol Ther; 2018 Oct; 48(7):723-730. PubMed ID: 30095176
[TBL] [Abstract][Full Text] [Related]
17. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
[TBL] [Abstract][Full Text] [Related]
18. Crohn's disease complicated by Epstein-Barr virus-driven haemophagocytic lymphohistiocytosis successfully treated with rituximab.
Thompson G; Pepperell D; Lawrence I; McGettigan BD
BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28228435
[TBL] [Abstract][Full Text] [Related]
19. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.
Balamuth NJ; Nichols KE; Paessler M; Teachey DT
J Pediatr Hematol Oncol; 2007 Aug; 29(8):569-73. PubMed ID: 17762500
[TBL] [Abstract][Full Text] [Related]
20. Epstein-barr virus-related diarrhea or exacerbation of inflammatory bowel disease: diagnostic dilemma.
Weinberg I; Neuman T; Margalit M; Ayman F; Wolf DG; Ben-Yehuda A
J Clin Microbiol; 2009 May; 47(5):1588-90. PubMed ID: 19279175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
